MacDougall C, Chambers H (2011) Aminogylcosides. In: Brunton L, Chamber B, Knollman B (eds) The pharmacological basis of therapeutics. Mc Graw Hill, New York, NY, USA, pp 1507–1517

Google Scholar 

Prayle A, Watson A, Fortnum H, Smyth A (2010) Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis. Thorax 65:654–658

Article  PubMed  Google Scholar 

Pitta RD, Gasparetto J, De Moraes TP, Telles JP, Tuon FF (2020) Antimicrobial therapy with aminoglycoside or meropenem in the intensive care unit for hospital associated infections and risk factors for acute kidney injury. Eur J Clin Microbiol Infect Dis 39(4):723–728

Article  CAS  PubMed  Google Scholar 

Soman R, Bakthavatchalam YD, Nadarajan A, Dwarakanathan HT, Venkatasubramanian R, Veeraraghavan B (2021) Is it time to move away from polymyxins?: evidence and alternatives. Eur J Clin Microbiol Infect Dis 40:461–475

Article  CAS  PubMed  Google Scholar 

Marsot A, Guilhaumou R, Riff C, Blin O (2017) Amikacin in critically Ill patients: A review of population pharmacokinetic studies. Clin Pharmacokinet 56:127–138

Article  CAS  PubMed  Google Scholar 

Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA (2020) Intensive Care Med 46:1127–1153

Article  PubMed  PubMed Central  Google Scholar 

Edwards MR, Mythen MG (2014) Fluid therapy in critical illness. Extrem Physiol Med 3:16

Article  PubMed  PubMed Central  Google Scholar 

Oparaoji EC, Cornwell EE, Hekmat E, Cheong RL, Adir JS, Siram S (1993) Aminoglycoside volume of distribution in postoperative patients with septic shock. Clin Pharm 12:131–134

CAS  PubMed  Google Scholar 

Taccone FS, Laterre PF, Spapen H, Dugernier T, Delattre I, Layeux B, De Backer D, Wittebole X, Wallemacq P, Vincent JL, Jacobs F (2010) Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care 14:R53

Article  PubMed  PubMed Central  Google Scholar 

Marik PE (1993) Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anaesth Intensive Care 21:172–173

Article  CAS  PubMed  Google Scholar 

Garraffo R, Drugeon HB, Dellamonica P, Bernard E, Lapalus P (1990) Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother 34(4):614–621

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lanao JM, Navarro AS, Dominguez-Gil A, Tabernero JM, Rodriguez IC, Gonzalez LA (1983) Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment. J Antimicrob Chemother 12(5):481–488

Article  CAS  PubMed  Google Scholar 

Delattre IK, Musuamba FT, Nyberg J, Taccone FS, Laterre PF, Verbeeck RK, Jacobs F, Wallemacq PE (2010) Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients. Ther Drug Monit 32(6):749–756

Article  CAS  PubMed  Google Scholar 

De Winter S, van Hest R, Dreesen E, Annaert P, Wauters J, Meersseman W, Van den Eede N, Desmet S, Verelst S, Vanbrabant P, Peetermans W, Spriet I (2021) Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis. Eur J Drug Metab Pharmacokinet 46(5):653–663

Article  PubMed  Google Scholar 

Meraz-Munoz A, Langote A, Jhaveri DK, Izzedine H, Gudsoorkar P (2021) Acute kidney injury in the patient with cancer. Diagnostics (Basel) 11(4):611

Article  CAS  PubMed  Google Scholar 

Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW, Rosenal T (2005) Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study. Crit Care 9:R700–R709

Article  PubMed  PubMed Central  Google Scholar 

Benoit DD, Hoste EA (2010) Acute kidney injury in critically ill patients with cancer. Crit Care Clin 26(1):151–179

Article  CAS  PubMed  Google Scholar 

Lode H, Grunert K, Koeppe P, Langmaack H (1976) Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. J Infect Dis 134(SUPPL):S316–S322

Article  CAS  PubMed  Google Scholar 

Mahmoudi L, Mohammadpour AH, Ahmadi A, Niknam R, Mojtahedzadeh M (2013) Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients. Eur Rev Med Pharmacol Sci 17(3):285–291

CAS  PubMed  Google Scholar 

Aréchiga-Alvarado NA, Mellín-Garibay SE, Milán-Segovia RC, Ortiz-Álvarez A, Magana-Aquino M, Romano-Moreno S (2020) Population pharmacokinetics of amikacin administered once daily in patients with different renal functions. Antimicrob Agents Chemother 64:e02178–e2219

Article  PubMed  PubMed Central  Google Scholar 

Holweger K, Lipp H-P, Dietz K, Hartmann JT, Bokemeyer C (2008) Novel algorithm for more accurate calculation of renal function in adults with cancer. Ann Pharmacother 42:1749–1757

Article  CAS  PubMed  Google Scholar 

Ainsworth NL, Marshall A, Hatcher H, Whitehead L, Whitfield GA, Earl HM (2012) Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients. Ann Oncol 23:1845–1853

Article  CAS  PubMed  Google Scholar 

Silva VTC, Costalonga EC, Coelho FO, Caires RA, Burdmann EA (2018) Assessment of kidney function in patients with cancer. Adv Chronic Kidney Dis 25:49–56

Article  Google Scholar 

Darwich AS, Polasek TM, Aronson JK, Ogungbenro K, Wright DFB, Achour B, Reny JL, Daali Y, Eiermann B, Cook J, Lesko L, McLachlan AJ, Rostami-Hodjegan A (2021) Model-informed precision dosing: background, requirements, validation, implementation, and forward trajectory of individualizing drug therapy. Annu Rev Pharmacol Toxicol 61:225–245

Article  CAS  PubMed  Google Scholar 

Lopes JA, Jorge S (2013) The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J 6(1):8–14

Article  PubMed  Google Scholar 

FDA (2020) Guidance for Industry Pharmacokinetics in patients with impaired renal function –study design, data analysis, and impact on dosing. Available at: https://www.fda.gov/media/78573/download. Accessed 04 Mar 2022.

Karlowsky JA, Zhanel GG (1992) Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides. Clin Infect Dis 15(4):654–667. https://doi.org/10.1093/clind/15.4.654

Article  CAS  PubMed  Google Scholar 

Debord J, Charmes JP, Marquet P, Merle L, Lachatre G (1997) Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm. Int J Clin Pharmacol Ther 35:24–27

CAS  PubMed  Google Scholar 

Sáez-Fernández EM, Pérez-Blanco JS, Lanao JM, Calvo MV, Martín-Suárez A (2019) Evaluation of renal function equations to predict amikacin clearance. Expert Rev Clin Pharmacol 12:805–813

Article  PubMed  Google Scholar 

Ryzner KL (2010) Evaluation of aminoglycoside clearance using the modification of diet in renal disease equation versus the Cockcroft-Gault equation as a marker of glomerular filtration rate. Ann Pharmacother 44:1030–1037

Article  CAS  PubMed  Google Scholar 

Chin P, Florkowski C, Begg E (2013) The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance. Ann Clin Biochem 50:546–557

Article  CAS  PubMed  Google Scholar 

Pickkers P, Darmon M, Hoste E, Joannidis M, Legrand M, Ostermann M, Prowle JR, Schneider A, Schetz M (2021) Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intensive Care Med 47(8):835–850

Article  PubMed  PubMed Central  Google Scholar 

Vallon V (2014) Do tubular changes in the diabetic kidney affect the susceptibility to acute kidney injury? Nephron Clin Pract 127(1–4):133–138

Article  CAS  PubMed  Google Scholar 

Vallon V, Thomson SC (2012) Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol 74:351–375

Article  CAS  PubMed  Google Scholar 

Murashima M, Nishimoto M, Kokubu M, Hamano T, Matsui M, Eriguchi M, Samejima KI, Akai Y, Tsuruya K (2019) Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery. Sci Rep 9(1):20260

Article  CAS  PubMed  PubMed Central  Google Scholar 

das Neves W, Alves CRR, de Souza Borges AP, de Castro G Jr (2021) Serum creatinine as a potential biomarker of skeletal muscle atrophy in non-small cell lung cancer patients. Front Physiol 12:625417

Article  PubMed  PubMed Central  Google Scholar 

Drescher C, Konishi M, Ebner N, Springer J (2015) Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment. J Cachexia Sarcopenia Muscle 6(4):303–311

Article  PubMed  PubMed Central